Medigoxin: Difference between revisions

	WikiDoc Resources for Medigoxin
Articles
Most recent articles on Medigoxin Most cited articles on Medigoxin Review articles on Medigoxin Articles on Medigoxin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Medigoxin Images of Medigoxin Photos of Medigoxin Podcasts & MP3s on Medigoxin Videos on Medigoxin
Evidence Based Medicine
Cochrane Collaboration on Medigoxin Bandolier on Medigoxin TRIP on Medigoxin
Clinical Trials
Ongoing Trials on Medigoxin at Clinical Trials.gov Trial results on Medigoxin Clinical Trials on Medigoxin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Medigoxin NICE Guidance on Medigoxin NHS PRODIGY Guidance FDA on Medigoxin CDC on Medigoxin
Books
Books on Medigoxin
News
Medigoxin in the news Be alerted to news on Medigoxin News trends on Medigoxin
Commentary
Blogs on Medigoxin
Definitions
Definitions of Medigoxin
Patient Resources / Community
Patient resources on Medigoxin Discussion groups on Medigoxin Patient Handouts on Medigoxin Directions to Hospitals Treating Medigoxin Risk calculators and risk factors for Medigoxin
Healthcare Provider Resources
Symptoms of Medigoxin Causes & Risk Factors for Medigoxin Diagnostic studies for Medigoxin Treatment of Medigoxin
Continuing Medical Education (CME)
CME Programs on Medigoxin
International
Medigoxin en Espanol Medigoxin en Francais
Business
Medigoxin in the Marketplace Patents on Medigoxin
Experimental / Informatics
List of terms related to Medigoxin

Medigoxin
Clinical data
ATC code	C01AA08 (WHO) ;
Identifiers
	IUPAC name 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-12,14-; Dihydroxy-3-; [(2R,4S,5S,6R)-4-hydroxy-; 5-[(2S,4S,5S,6R)-4-hydroxy-; 5-[(2S,4S,5S,6R)-4-hydroxy-; 5-methoxy-6-methyl-oxan-2-yl]oxy-; 6-methyl-oxan-2-yl]oxy-6-methyl-; oxan-2-yl]oxy-10,13-dimethyl-; 1,2,3,4,5,6,7,8,9,11,12,15,16,17-; tetradecahydrocyclopenta[a]phenanthren-; 17-yl]-5H-furan-2-one;
CAS Number	30685-43-9;
PubChem CID	35418;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C42H66O14
Molar mass	794.965

Revision as of 15:34, 23 July 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Metildigoxin (INN, or medigoxin BAN, or methyldigoxin) is a cardiac glycoside,^[1] a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). The substance is closely related to digoxin; it differs from the latter only by an O-methyl group on the terminal monosaccharide.

↑ PMID 6849743 (PMID 6849743)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

@@ Line 23: / Line 23: @@
 ==Overview==
-'''Medigoxin''' (or '''metildigoxin''') is a [[cardiac glycoside]] closely related to [[digoxin]].
+'''Metildigoxin''' ([[International Nonproprietary Name|INN]], or '''medigoxin''' [[British Approved Name|BAN]], or '''methyldigoxin''') is a [[cardiac glycoside]],<ref>{{cite pmid|6849743}}</ref> a type of drug that can be used in the treatment of [[congestive heart failure]] and [[cardiac arrhythmia]] (irregular heartbeat). The substance is closely related to [[digoxin]]; it differs from the latter only by an O-[[methyl]] group on the terminal [[monosaccharide]].
+==References==
+{{reflist}}
 {{Cardiac glycosides}}

Clinical data

ATC code	C01AA08 (WHO)
Identifiers
IUPAC name 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-12,14- Dihydroxy-3- [(2R,4S,5S,6R)-4-hydroxy- 5-[(2S,4S,5S,6R)-4-hydroxy- 5-[(2S,4S,5S,6R)-4-hydroxy- 5-methoxy-6-methyl-oxan-2-yl]oxy- 6-methyl-oxan-2-yl]oxy-6-methyl- oxan-2-yl]oxy-10,13-dimethyl- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthren- 17-yl]-5H-furan-2-one
CAS Number	30685-43-9
PubChem CID	35418
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₄₂H₆₆O₁₄
Molar mass	794.965